BioSpace News Archive

Policy

iReceptor Plus Consortium to Host Joint SCAIR Community Event

As part of the continued expansion of the iReceptor Plus stakeholder’s community, a special partner meeting will be held in Haifa in parallel with the third SCAIR meeting

November 18, 2019
·
2 min read
InDex Pharmaceuticals Presents at Redeye Life Science Day and Avanza Börsdag November 19, 2019

InDex Pharmaceuticals Holding AB announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19.

November 18, 2019
·
2 min read
Drug Development

Medivir Reports Last Patient Recruited to the Phase Ia Study of MIV-818 in Liver Cancer Patients and Initial Dose Determined for phase Ib

Medivir AB reports that the ninth and final patient was recruited to the phase Ia study of MIV-818 in patients with advanced liver cancer.

November 18, 2019
·
3 min read
Scandinavian ChemoTech and its CEO Mohan Frick Participates and Presents at the Emerging Medtech Summit in California, USA

Scandinavian ChemoTech and its CEO Mohan Frick has been selected to present its Tumour Specific Electroporation at the Emerging Medtech Summit in California, USA.

November 18, 2019
·
1 min read
Deals

Hikma Ventures leads Series A financing for development of Winterlight Labs’ AI vocal technology to detect central nervous system disorders and track efficacy of treatments

Hikma Pharmaceuticals PLC, announces that its venture capital arm, Hikma Ventures has led a CAD 5.6 million oversubscribed round of financing for Winterlight Labs Inc. with participation from First Star Ventures, Pacific Health Ventures, existing investor Grey Sky Venture Partners and other investors.

November 18, 2019
·
4 min read
Policy

ITM and CIRC Sign Technology License Agreement for the Production and Distribution of Medical Radioisotopes in China

ITM Isotopen Technologien München AG and Chengdu Gaotong Isotope Co., Ltd. announced that they have signed a technology license agreement for the production and distribution of ITM Germanium-68/Gallium-68 Generators and no-carrier-added Lutetium-177 in China.

November 18, 2019
·
3 min read
RhoVac Reports Interim Results on Immunological Response with RV001

Today, 18th November 2019, RhoVac AB reports interim results from ongoing immunological studies at University of Tübingen, Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells.

November 18, 2019
·
2 min read
Policy

MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China

Buffalo-based clinical-stage biotechnology company MimiVax, a Roswell Park Comprehensive Cancer Center spinoff, set to work with leading healthcare group in China to provide promising immunotherapy

November 18, 2019
·
4 min read
Drug Development

Karuna Therapeutics Announces KarXT Met Primary Endpoint in Phase 2 Clinical Trial of Acute Psychosis in Patients with Schizophrenia

KarXT Demonstrated Statistically Significant and Clinically Meaningful Improvement in Total PANSS Score at All Time Points Over Five Weeks and was Well-Tolerated Compared to Placebo

November 18, 2019
·
8 min read
Drug Development

AVEO Announces Presentation of Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma

Tivozanib Significantly Improves PFS and ORR Compared to Sorafenib and Demonstrates Updated Interim OS HR of 0.99 in Refractory Advanced RCC

November 18, 2019
·
11 min read